docetaxel,darolutamide
bayer
['#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'docetaxel', 'arasens']
the disease volume analysis of arasens is inconclusive for tx effect heterogeneity. there is significant uncertainty for low volume men given the low numbers. questions remains for the utility of adding docetaxel to adt + asi #gu23 
Genitourinary Medical Oncologist @MDAndersonNews.  Opinions are my own.